The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk

Lee, Yun S.; Kindinger, Lindsay M.; Bennett, Phillip R.; Marchesi, Julian R.; Smith, Ann; Cacciatore, Stefano; Holmes, Elaine; Nicholson, Jeremy K.; Teoh, T. G.; MacIntyre, David A.

doi:10.1186/s40168-016-0223-9

All Outputs (6)

Ticarcillin hypersusceptibility in pseudomonas aeruginosa in cystic fibrosis (2017)
Journal Article
Duckers, J., Hettiarachchi, I., Wootton, M., O’Sullivan, T., & Smith, A. (in press). Ticarcillin hypersusceptibility in pseudomonas aeruginosa in cystic fibrosis. Archives of Pulmonology and Respiratory Care, 3(1), 067-071. https://doi.org/10.17352/aprc.000028

Comparison of vaginal microbiota sampling techniques: Cytobrush versus swab (2017)
Journal Article
Mitra, A., MacIntyre, D. A., Mahajan, V., Lee, Y. S., Smith, A., Marchesi, J. R., …Kyrgiou, M. (2017). Comparison of vaginal microbiota sampling techniques: Cytobrush versus swab. Scientific Reports, 7(1), https://doi.org/10.1038/s41598-017-09844-4

© 2017 The Author(s). Evidence suggests the vaginal microbiota (VM) may influence risk of persistent Human Papillomavirus (HPV) infection and cervical carcinogenesis. Established cytology biobanks, typically collected with a cytobrush, constitute a... Read More about Comparison of vaginal microbiota sampling techniques: Cytobrush versus swab.

Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study (2017)
Journal Article
Thursz, M. R., Cobbold, J. F., Atkinson, S., Marchesi, J. R., Smith, A., Wai, S. N., …Umpleby, A. M. (2018). Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study. Hepatology Research, 48(1), 69-77. https://doi.org/10.1111/hepr.12904

© 2017 The Japan Society of Hepatology. Aim: Gut microbial dysbiosis is implicated in the pathogenesis of non-alcoholic steatohepatitis (NASH). We investigated downstream effects of gut microbiota modulation on markers of hepatic inflammation, steato... Read More about Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study.

Endotracheal tubes and fluid aspiration: An in vitro evaluation of new cuff technologies (2017)
Journal Article
Mariyaselvam, M. Z., Marsh, L. L., Bamford, S., Smith, A., Wise, M. P., & Williams, D. W. (2017). Endotracheal tubes and fluid aspiration: An in vitro evaluation of new cuff technologies. BMC Anesthesiology, 17(1), https://doi.org/10.1186/s12871-017-0328-0

© 2017 The Author(s). Background: Aspiration of subglottic secretions past the endotracheal tube (ETT) cuff is a prerequisite for developing ventilator-associated pneumonia (VAP). Subglottic secretion drainage (SSD) ETTs reduce aspiration of subglott... Read More about Endotracheal tubes and fluid aspiration: An in vitro evaluation of new cuff technologies.

Community analysis of dental plaque and endotracheal tube biofilms from mechanically ventilated patients (2017)
Journal Article
Marino, P. J., Wise, M. P., Smith, A., Marchesi, J. R., Riggio, M. P., Lewis, M. A., & Williams, D. W. (2017). Community analysis of dental plaque and endotracheal tube biofilms from mechanically ventilated patients. Journal of Critical Care, 39, 149-155. https://doi.org/10.1016/j.jcrc.2017.02.020

© 2017 Elsevier Inc. Purpose Mechanically ventilated patients are at risk for developing ventilator-associated pneumonia, and it has been reported that dental plaque provides a reservoir of respiratory pathogens that may aspirate to the lungs and end... Read More about Community analysis of dental plaque and endotracheal tube biofilms from mechanically ventilated patients.

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk (2017)
Journal Article
Lee, Y. S., Kindinger, L. M., Bennett, P. R., Marchesi, J. R., Smith, A., Cacciatore, S., …MacIntyre, D. A. (2017). The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome, 5(1), Article 9802. https://doi.org/10.1186/s40168-016-0223-9

© The Author(s) 2017. Background: Preterm birth is the primary cause of infant death worldwide. A short cervix in the second trimester of pregnancy is a risk factor for preterm birth. In specific patient cohorts, vaginal progesterone reduces this ris... Read More about The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.